New Climbing Rope Raises Funds for Ovarian Cancer Research

Avatar:
Author:
Publish date:
Social count:
0
New Climbing Rope Raises Funds for Ovarian Cancer Research

BlueWater Ropes Introduces Women’s Life Line with the HERA Lightning Pro(February 25, 2008—Carbondale, Colo.) BlueWater Ropes is donating $15.00 from every sale of their new teal color combination 9.7mm 60-meter HERA Lightning Pro rope to the HERA Women’s Cancer Foundation. The HERA rope packs small and is lightweight, making it ideal for high-end endeavors, from sport climbing to big-wall-in-a-day alpine routes. The rope retails for $185.99 and is available at Blackjack Mountain Outfitters.com. Shipping is free, and each rope includes a HERA Partners in Action ovarian cancer–awareness hangtag to help raise awareness of the disease’s symptoms. “We build ropes that protect our customers’ safety, so for BlueWater the HERA rope is a natural extension of our daily mission, since HERA protects women’s safety,” says Scott Newell, CEO of the Carrollton, Georgia–based rope manufacturer. “Too many lives have been impacted by cancer. By working with HERA and with our customers, we can make a difference.” BlueWater Ropes has been sponsoring the HERA Climb4Life event series since its inception in 2002.About HERA Partners in ActionThe HERA Partners in Action program enables companies to “give back” a portion of sales from a product or group of products to the HERA Women’s Cancer Foundation. Designated Partners in Action products include hangtags that educate consumers about ovarian cancer facts and symptoms. The Partners in Action program includes outdoor gear manufacturers such as BlueWater Ropes, www.climbingholds.com, Dare to Dream Expedition, Evolv, MadRock, Petzl and Zensah Performance Apparel. For more information contact Stephanie Forte at Forte Creative Media, 702.898.2547.About the HERA FoundationThe HERA Foundation is a registered 501 (c) 3, whose mission is to stop the loss of mothers, daughters, wives, sisters, partners and girlfriends from ovarian cancer by empowering women to take control of their health, empowering the medical community to find new directions in ovarian cancer research and empowering communities to provide support For more information, visit www.herafoundation.org.